Carisma Therapeutics Inc.
CARMDelisted Dec 15, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001485003
Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Carisma Therapeutics Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 37 | 53 | +16 |
| Shares | 5.57M | 9.58M | +4.01M (+72.0%) |
| Value | $17.3M | $84.0M | +$66.8M (+386.5%) |
New holders (25)
Institutions that held Carisma Therapeutics Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (9)
Institutions that held Carisma Therapeutics Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| BML Capital Management, LLC | 411,398 | $1.28M |
| Deuterium Capital Management, LLC | 51,256 | $158.9K |
| Wittenberg Investment Management, Inc. | 46,703 | $144.8K |
| Millennium Management LLC | 35,673 | $111.0K |
| Stratos Wealth Partners, LTD. | 19,899 | $61.7K |
| Jump Financial, LLC | 17,542 | $54.4K |
| Virtu Financial LLC | 15,335 | $48.0K |
| Tortoise Investment Management, LLC | 200 | $620 |
| Hantz Financial Services, Inc. | 30 | $0 |